LINC01841

Across TCGA pan-cancer cohorts, LINC01841 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated LINC01841 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher LINC01841 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01841 expression acts as an unfavorable survival marker, although some lineages such as LUAD and BLCA show a favorable association.

ACC, LUAD, and KIRC are the cancer types where LINC01841 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Tertile	All	0.586	0.880	<.001	99	view →
LUAD	OS	Tertile	II,III,IV	0.383	0.173	<.001	65	view →
KIRC	OS	Median	All	0.559	0.749	<.001	58	view →
LGG	OS	Median	All	0.324	0.532	<.001	54	view →
BLCA	OS	Median	III,IV	0.722	0.587	.002	41	view →
LUSC	DFS	Median	II,III,IV	0.503	0.677	.005	24	view →
HNSC	DFS	Quartile	III,IV	0.690	0.513	.014	21	view →
LIHC	DFS	Median	III,IV	0.219	0.431	.003	18	view →
STAD	DFS	Quartile	IV	1.000	0.292	.016	16	view →
CHOL	OS	Median	II,III,IV	1.000	0.127	.049	6	view →
GBM	OS	Median	All	0.513	0.309	.023	5	view →
THCA	DFS	Median	IV	0.763	0.444	.041	4	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

LINC01841–ACC (OS)

Open the ACC breakdown →